In 2025, the Detroit Lions wasted no time in a bad way when they only interviewed one offensive coordinator candidate and ...
Mayor Zohran Mamdani gave an exclusive interview to FOX 5 NY's political reporter Morgan McKay, where he spoke about his ...
Organon (OGN) ended the recent trading session at $6.98, demonstrating a +2.2% change from the preceding day's closing price. This change outpaced the S&P 500's 0.64% gain on the day. Elsewhere, the ...
A woman’s story about being asked an unexpected question during a job interview has gone viral on social media, sparking discussion about honesty, self-awareness, and workplace values. The post, ...
Organon (OGN) just scored a major win alongside partner Henlius, as the FDA approved POHERDY, the first pertuzumab biosimilar available in the US. This milestone could open up new revenue streams and ...
Organon (OGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...
The Organon board of directors has approved the deal. The transaction is expected to close in the first quarter of 2026, subject to required regulatory approvals. “I am incredibly proud of the work ...
Organon (NYSE:OGN) reported better-than-expected earnings for the third quarter on Monday. The company posted third-quarter adjusted earnings of $1.01 per share on Monday, beating the consensus ...
Organon (NYSE:OGN) reported third-quarter adjusted earnings of $1.01 per share on Monday, beating the consensus estimate of 94 cents. The global healthcare company reported quarterly sales of $1.602 ...
JERSEY CITY, N.J. (AP) — JERSEY CITY, N.J. (AP) — Organon & Co. (OGN) on Monday reported third-quarter earnings of $160 million. The Jersey City, New Jersey-based company said it had profit of 61 ...